Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Didn't DM state that Zen-3694 was planning an application for accelerated approval for nut carcinoma (NCT 05019716) current estimated Phase 1/2 trial completion 12/01/2024?
